Susan Thornton, Chair
Cutaneous Lymphoma Foundation
Susan Thornton is the CEO of the Cutaneous Lymphoma Foundation, and was elected Chair of the Board of Lymphoma Coalition on 31 January 2018. She has also served as a Founding Board Member/Vice Chair of the International Alliance of Dermatology Patient Organizations and Vice Chair of the Coalition of Skin Diseases.
Prior to joining the CLF as CEO, she served on the Board of Directors and provided consulting services to the Foundation. Ms. Thornton spent over 25 years in the healthcare technology field, holding various positions in consulting, marketing and sales.
She holds a business degree from The University of Pennsylvania Wharton School and completed the Non-Profit Certification Program at the University of Pennsylvania. In addition to her CLF Board service, she served on the boards of the Leukemia & Lymphoma Society, Eastern Pennsylvania Chapter, Tristate Multisport Association and the Sierra Club, Philadelphia Chapter. She is a native of Philadelphia and has completed 17 triathlons, raising money for cancer research.
Rosmarie Pfau, Vice Chair
Rosmarie Pfau is Founder and President of Lymphome.ch Patientennetz Schweiz (formerly ho/noho).
In 1999, Rosmarie was diagnosed with a follicular lymphoma and had to go through treatments, such as chemotherapy, immunotherapy, radioimmunotherapy, radiation and finally, after a lymphoma transformation, a high-dose chemotherapy with autologous stem-cell transplantation in 2006.
Due to the fact that there was a lack of information, resources and support for lymphoma patients and their relatives, Rosmarie set up the first lymphome.ch patient support group in Basel, Switzerland in May 2001, which was followed by other groups in different Swiss regions.
She is a founding member and executive board member of EUPATI CH, as well as being a EUPATI fellow. Rosmarie is a board member of the Cancer League Basel, a member of the patient advisory board of SAKK (the Swiss Society for Clinical Cancer Research), a member of the Swissmedic Working Group for patient and consumer organisations and other Swiss and European working groups and advisory boards.
Her main concern is helping to raise awareness and understanding of lymphomas; to establish and provide information; and to give emotional support and guidance to patients and relatives in the course of their journey.
Lymphome.ch became a member of the Lymphoma Coalition in 2004. Rosmarie joined the Lymphoma Coalition Board of Directors in 2014 and was elected Vice Chair in 2018.
Guy Bouguet, Treasurer
France Lymphome Espoir
Guy Bouguet is President of France Lymphome Espoir. Guy is an Electronic Engineer who worked over 10 years in the Silicon Valley for one of the largest semiconductor company.
In 2000, Guy was diagnosed with follicular lymphoma and received several treatments such as radiation therapies, chemotherapies and immunotherapies. In 2003, he underwent an autologous bone marrow transplant and unfortunately, the lymphoma returned in May 2005. Guy had an Allograft in November of the same year.
In his search for information and understanding of his illness, he found very little that would satisfy his needs in France. So in February 2006, he founded France Lymphome Espoir.
Now in remission, Guy is dedicated to raising awareness of lymphoma, advocating for best access to care and providing information to patients. In 2011 Guy became a Board member of the Lymphoma Coalition.
Dr. Sarper Diler, Secretary
Professor DILER (M.D., PhD, CHTC) is a staff Professor at Istanbul University Medical Faculty and holds Hematopoietic Stem Cell Transplantation Coordinatorship Certificate of the National Marrow Donor Programme (NMDP, USA), consulting international Stemcell Transplantation centers at various universities and advisor at Turkish Social Security Institution (SGK). He is mainly working with KIR Genes, HLA polymorphism, disease associations and specialised in biobanking (bone marrow, cord blood, tissue).
Prof DILER is the co-founder and CEO of BIRKAN and Cancer Coalition of Turkey (KANKO). He is a member of Patients Advisory Committee (PAC) of ECCO (European Cancer Organisation), as well as responsible for the inter-organisational networking of Middle East-African Cancer Advocacy Leaders (CALAMEA) and member of World Marrow Donor Association (WMDA).
Sarper has been a Board member of the Lymphoma Coalition since 2011.
Monica Pasqualin, Director
Brazilian Lymphoma and Leukemia Society – ABRALE, Brazil
Monica Pasqualin is an economist with a degree in Political Sciences, Marketing and Social Management. She has more than 20 years of experience at corporate and nonprofit institutions. Presently, she is the Head of Strategic Alliances, Fundraising at ABRALE – Brazilian Lymphoma and Leukemia Society, founded in 2002 and one of the most prestigious patient advocacy organizations in Brazil and Latin America.
She also heads the Alianza Latina programme at ABRALE, coordinating a network of 122 patient advocacy institutions across Latin America, the USA, Spain and Portugal. ABRALE is the founding member and one of the leaders of the All Against Cancer Movement in Brazil, a well-known programme that unites public and private stakeholders to enhance knowledge and policies relating to the most relevant issues in oncology.
Lauren Pretorius, Director
Campaigning for Cancer, South Africa
Lauren Pretorius is the CEO and co-founder of Campaigning for Cancer NPC, an advocacy patient group formed in 2008 to lobby for the promotion and protection of patients’ rights with regards to policy, healthcare costs and healthcare delivery.
Pretorius has worked in the cancer civil society since 2005. She was the chief operating officer of Breast Health Foundation, a co-founder of Bosom Buddies and a consultant to the Prostrate Cancer Foundation of South Africa and various other cancer charities. Pretorius managed the pilot LIVESTRONG/American Cancer Society’s SEI Survivor Forum in South Africa and has represented South Africa as a Global Cancer Ambassador for the UN’s Resolution for Non Communicable Diseases. She chaired the Civil Society Commission at the National Department of Health’s NCD Summit and was a member of National Cancer Registry implementation team as well as a founding member of the executive committee of the Cancer Alliance.
As a specialist consultant, she assisted a number of non-profit organisations to apply business principles and marketing strategies to ensure their greater success and sustainability. From 2000 to 2003 she was contracted to the Nelson Mandela’s Children Fund on brand governance and fundraising partner. She was privileged to work with Nelson Mandela Foundation on the launch of their 46664 brand.
Lorna Warwick, CEO
Lorna Warwick was appointed CEO of the Lymphoma Coalition in December 2018 and prior to that was the Coalition’s Director of Strategic Communications and Engagement. Lorna has successfully held senior leadership roles in health charities for more than twenty years and has a diverse background in patient advocacy, mission development, communications and strategic planning.
Her efforts have been focused on haematological cancers since 2003, at a national (Canada) and global level. As a result of her years of experience in advocacy and especially in the haematology field, she is frequently asked to present on emerging trends and critical issues in the lymphoma and CLL landscape.
Past Chair: Pru Etcheverry, Auckland, NZ
Last updated 12/2018